Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2019 /
Clinical trials in Africa: Bench to bedside

29th Mar - 3rd Apr 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.04.19
Views: 641

Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria

Prof Ifeoma Okoye speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about her advocacy for improved cancer control and for more clinical trials in Africa.

Prof Okoye also explains the epidemiological burden that Africa are currently experiencing with the high prevalence of communicable diseases.

Prof Okoye highlights the significance of clinical trials and genome-wide studies, as a method to identify the genetic and environmental drivers of cancer in the population.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation